Given the pivotal role of the EGFR signaling pathway in regulating tumorigenesis, cell growth, and proliferation in NSCLC, the EGFR emerges as an attractive therapeutic target [7]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.